This is a community-generated profile. If you would like to claim it, please .
Corvus Pharmaceuticals
Develops first-in-class agents that target the immune system to treat cancer51-200 EmployeesActively Hiring
Corvus Pharmaceuticals Funding
$30.6M
11 round
Corvus Pharmaceuticals is active in the following markets / industries: B2B and professional services. The company has secured funding across 1 rounds, totaling in an amount of $30.6M. Their most recent funding was raised on May 2, 2024.
Funding Rounds
S
$30600000